TrademarkDir
XANTHOS
LIVE

Serial Number

79322627

Owner

Celeris Therapeutics GmbH

Attorney

Vincent J. Badolato

Filing Date

Apr 29, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

XANTHOS Trademark

Serial Number: 79322627 • Registration: 6874657

XANTHOS is a trademark filed by Celeris Therapeutics GmbH on April 29, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Celeris Therapeutics GmbH (6 trademarks)

Salzamtsgasse 7

Entity Type: 16

Trademark Details

Filing Date

April 29, 2021

Registration Date

October 18, 2022

Published for Opposition

August 2, 2022

Goods & Services

Scientific and technological services, namely, scientific research, analysis, and testing of molecules, proteins and drugs and other chemical substances, in the field of early phase of drug development in the chemical industry; scientific services, namely, identifying new drug compounds from analysis of molecules, proteins and drugs and other chemical substances; information technology consulting services for the chemical and pharmaceutical industries, as well as related industries, namely, cosmetics and the food industry; Product quality testing, authentication and quality control for others in the chemical and pharmaceutical industries for drug, protein, food chemistry, cosmetics and materials science development

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 1, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 1, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 1, 2025 REAP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 22, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 22, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 22, 2024 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 6, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 10, 2023 FICS
FINAL DISPOSITION PROCESSED
Feb 10, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 18, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 18, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 18, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Aug 2, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 2, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 2, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 13, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 13, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 24, 2022 TROA
REFUSAL PROCESSED BY IB
Feb 20, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 3, 2022 RFCS
REFUSAL PROCESSED BY MPU
Feb 2, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 12, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jan 11, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 29, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 22, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 18, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 14, 2021 REPR

Related Trademarks

More from this Owner

CELERIS THERAPEUTICS

CELERIS THERAPEUTICS

CELERISTX

CELERISTX

HADES

HADES

HADES

HADES

HADES

HADES

HEPHAISTOS

HEPHAISTOS